CompletedPhase 4ACTRN12606000503527

The effect of propofol or propofol plus midazolam and/or fentanyl on cognitive impairment following colonoscopy


Sponsor

Melbourne Health Research Directorate

Enrollment

200 participants

Start Date

Dec 6, 2006

Study Type

Interventional

Conditions

Summary

Patients having colonoscopy under sedation may remain sedated for some hours afterwards. This may mean that they cannot return to work inside or outside the home. Our hypothesis is that patients who receive midazolam and fentanyl, as well as propofol, will be more sedated than those who receive propofol alone, at the time of hospital discharge.


Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Inclusion Criteria1

  • Patients who present for elective outpatient colonoscopy, not combined with other procedures and following full bowel preparation.

Exclusion Criteria1

  • Patients with cognitive deficits and without adequate English language comprehension.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

2. Sedation individually titrated for patient requirement for the duration of colonoscopy (10-60 minutes) with variable dose intravenous propofol (50-400 mg) plus variable dose intravenous midazolam (

2. Sedation individually titrated for patient requirement for the duration of colonoscopy (10-60 minutes) with variable dose intravenous propofol (50-400 mg) plus variable dose intravenous midazolam (0.5-5 mg) and/or variable dose intravenous fentanyl (10-100 mcg)


Locations(1)

VIC, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12606000503527